Heckl, S.M.; Mau, F.; Senftleben, A.; Daunke, T.; Beckinger, S.; Abdullazade, S.; Schreiber, S.; Röcken, C.; Sebens, S.; Schäfer, H.
Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control. Med. Sci. 2021, 9, 48.
https://doi.org/10.3390/medsci9030048
AMA Style
Heckl SM, Mau F, Senftleben A, Daunke T, Beckinger S, Abdullazade S, Schreiber S, Röcken C, Sebens S, Schäfer H.
Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control. Medical Sciences. 2021; 9(3):48.
https://doi.org/10.3390/medsci9030048
Chicago/Turabian Style
Heckl, Steffen M., Franziska Mau, Anke Senftleben, Tina Daunke, Silje Beckinger, Samir Abdullazade, Stefan Schreiber, Christoph Röcken, Susanne Sebens, and Heiner Schäfer.
2021. "Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control" Medical Sciences 9, no. 3: 48.
https://doi.org/10.3390/medsci9030048
APA Style
Heckl, S. M., Mau, F., Senftleben, A., Daunke, T., Beckinger, S., Abdullazade, S., Schreiber, S., Röcken, C., Sebens, S., & Schäfer, H.
(2021). Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control. Medical Sciences, 9(3), 48.
https://doi.org/10.3390/medsci9030048